Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.

Dexamethasone has been shown to reduce mortality in patients with tuberculous meningitis but the long-term outcome of the disease is unknown.Vietnamese adults and adolescents with tuberculous meningitis recruited to a randomised, double-blind, placebo-controlled trial of adjunctive dexamethasone wer...

Full description

Bibliographic Details
Main Authors: M Estée Török, Duc Bang Nguyen, Thi Hong Chau Tran, Thi Bich Yen Nguyen, Guy E Thwaites, Thi Quy Hoang, Huy Dung Nguyen, Tinh Hien Tran, Tran Chinh Nguyen, Hoang Thi Thanh Hoang, Marcel Wolbers, Jeremy J Farrar
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3234244?pdf=render
_version_ 1818275389329375232
author M Estée Török
Duc Bang Nguyen
Thi Hong Chau Tran
Thi Bich Yen Nguyen
Guy E Thwaites
Thi Quy Hoang
Huy Dung Nguyen
Tinh Hien Tran
Tran Chinh Nguyen
Hoang Thi Thanh Hoang
Marcel Wolbers
Jeremy J Farrar
author_facet M Estée Török
Duc Bang Nguyen
Thi Hong Chau Tran
Thi Bich Yen Nguyen
Guy E Thwaites
Thi Quy Hoang
Huy Dung Nguyen
Tinh Hien Tran
Tran Chinh Nguyen
Hoang Thi Thanh Hoang
Marcel Wolbers
Jeremy J Farrar
author_sort M Estée Török
collection DOAJ
description Dexamethasone has been shown to reduce mortality in patients with tuberculous meningitis but the long-term outcome of the disease is unknown.Vietnamese adults and adolescents with tuberculous meningitis recruited to a randomised, double-blind, placebo-controlled trial of adjunctive dexamethasone were followed-up at five years, to determine the effect of dexamethasone on long-term survival and neurological disability.545 patients were randomised to receive either dexamethasone (274 patients) or placebo (271 patients). 50 patients (9.2%) were lost to follow-up at five years. In all patients two-year survival, probabilities tended to be higher in the dexamethasone arm (0.63 versus 0.55; p = 0.07) but five-year survival rates were similar (0.54 versus 0.51, p = 0.51) in both groups. In patients with grade 1 TBM, but not with grade 2 or grade 3 TBM, the benefit of dexamethasone treatment tended to persist over time (five-year survival probabilities 0.69 versus 0.55, p = 0.07) but there was no conclusive evidence of treatment effect heterogeneity by TBM grade (p = 0.36). The dexamethasone group had a similar proportion of severely disabled patients among survivors at five years as the placebo group (17/128, 13.2% vs. 17/116, 14.7%) and there was no significant association between dexamethasone treatment and disability status at five years (p = 0.32).Adjunctive dexamethasone appears to improve the probability of survival in patients with TBM, until at least two years of follow-up. We could not demonstrate a five-year survival benefit of dexamethasone treatment which may be confined to patients with grade 1 TBM.ClinicalTrials.gov NCT01317654.
first_indexed 2024-12-12T22:28:58Z
format Article
id doaj.art-b9e6b20edca641c3ba8f9e129b2445c2
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T22:28:58Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b9e6b20edca641c3ba8f9e129b2445c22022-12-22T00:09:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01612e2782110.1371/journal.pone.0027821Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.M Estée TörökDuc Bang NguyenThi Hong Chau TranThi Bich Yen NguyenGuy E ThwaitesThi Quy HoangHuy Dung NguyenTinh Hien TranTran Chinh NguyenHoang Thi Thanh HoangMarcel WolbersJeremy J FarrarDexamethasone has been shown to reduce mortality in patients with tuberculous meningitis but the long-term outcome of the disease is unknown.Vietnamese adults and adolescents with tuberculous meningitis recruited to a randomised, double-blind, placebo-controlled trial of adjunctive dexamethasone were followed-up at five years, to determine the effect of dexamethasone on long-term survival and neurological disability.545 patients were randomised to receive either dexamethasone (274 patients) or placebo (271 patients). 50 patients (9.2%) were lost to follow-up at five years. In all patients two-year survival, probabilities tended to be higher in the dexamethasone arm (0.63 versus 0.55; p = 0.07) but five-year survival rates were similar (0.54 versus 0.51, p = 0.51) in both groups. In patients with grade 1 TBM, but not with grade 2 or grade 3 TBM, the benefit of dexamethasone treatment tended to persist over time (five-year survival probabilities 0.69 versus 0.55, p = 0.07) but there was no conclusive evidence of treatment effect heterogeneity by TBM grade (p = 0.36). The dexamethasone group had a similar proportion of severely disabled patients among survivors at five years as the placebo group (17/128, 13.2% vs. 17/116, 14.7%) and there was no significant association between dexamethasone treatment and disability status at five years (p = 0.32).Adjunctive dexamethasone appears to improve the probability of survival in patients with TBM, until at least two years of follow-up. We could not demonstrate a five-year survival benefit of dexamethasone treatment which may be confined to patients with grade 1 TBM.ClinicalTrials.gov NCT01317654.http://europepmc.org/articles/PMC3234244?pdf=render
spellingShingle M Estée Török
Duc Bang Nguyen
Thi Hong Chau Tran
Thi Bich Yen Nguyen
Guy E Thwaites
Thi Quy Hoang
Huy Dung Nguyen
Tinh Hien Tran
Tran Chinh Nguyen
Hoang Thi Thanh Hoang
Marcel Wolbers
Jeremy J Farrar
Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.
PLoS ONE
title Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.
title_full Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.
title_fullStr Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.
title_full_unstemmed Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.
title_short Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.
title_sort dexamethasone and long term outcome of tuberculous meningitis in vietnamese adults and adolescents
url http://europepmc.org/articles/PMC3234244?pdf=render
work_keys_str_mv AT mesteetorok dexamethasoneandlongtermoutcomeoftuberculousmeningitisinvietnameseadultsandadolescents
AT ducbangnguyen dexamethasoneandlongtermoutcomeoftuberculousmeningitisinvietnameseadultsandadolescents
AT thihongchautran dexamethasoneandlongtermoutcomeoftuberculousmeningitisinvietnameseadultsandadolescents
AT thibichyennguyen dexamethasoneandlongtermoutcomeoftuberculousmeningitisinvietnameseadultsandadolescents
AT guyethwaites dexamethasoneandlongtermoutcomeoftuberculousmeningitisinvietnameseadultsandadolescents
AT thiquyhoang dexamethasoneandlongtermoutcomeoftuberculousmeningitisinvietnameseadultsandadolescents
AT huydungnguyen dexamethasoneandlongtermoutcomeoftuberculousmeningitisinvietnameseadultsandadolescents
AT tinhhientran dexamethasoneandlongtermoutcomeoftuberculousmeningitisinvietnameseadultsandadolescents
AT tranchinhnguyen dexamethasoneandlongtermoutcomeoftuberculousmeningitisinvietnameseadultsandadolescents
AT hoangthithanhhoang dexamethasoneandlongtermoutcomeoftuberculousmeningitisinvietnameseadultsandadolescents
AT marcelwolbers dexamethasoneandlongtermoutcomeoftuberculousmeningitisinvietnameseadultsandadolescents
AT jeremyjfarrar dexamethasoneandlongtermoutcomeoftuberculousmeningitisinvietnameseadultsandadolescents